DBV’s fi­nanc­ing for peanut al­ler­gy patch; Ei­sai di­vests pro­ton pump in­hibitor in Chi­na

Plus, news about Palatin, Spero and BioAt­la:

DBV Tech­nolo­gies’ $306M fi­nanc­ing: The French biotech could get up to that amount to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.